SSKYESkye Bioscience, Inc. Common Stock

Skye Bioscience, Inc. Common Stock

SKYE

$1.60+1.91%

Delayed · as of Oct 15, 2026, 1:16 PM ET

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive SKYE chart

  • Mkt cap

    $25.00M

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • Revenue

    N/A

  • EPS (H1 2026)

    $-0.59

  • Gross Margin

    N/A

  • Profit Margin

    N/A

  • Beta

    N/A

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

Live SKYE terminalLician Pro · $19.99/mo or $149/yrPeer financials on ProAPI free 100/dayCompare AAPL vs MSFT

SKYE — Skye Bioscience, Inc. Common Stock · $25.0M cap

SKYE Key Statistics

  • Market Cap: $25.0M
  • P/B Ratio: 2.80
  • Previous Close: $1.57
  • Volume: 11,093
  • Day Range: $1.55 – $1.65

SKYE FAQ

What industry is SKYE in?

Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company in the Healthcare sector.

What is SKYE's market cap?

Skye Bioscience, Inc. Common Stock (SKYE) market capitalization is $25.0M on the latest cached snapshot.

What are SKYE's previous close, day range, and volume?

Skye Bioscience, Inc. Common Stock (SKYE) cached previous close $1.57; day range $1.55 – $1.65; volume 11,093. Session quote: https://lician.com/quote/skye

Live SKYE terminal loads when you scroll near this section.